Chondroadherin (CHAD) Peptide
-
- Target See all CHAD products
- CHAD (Chondroadherin (CHAD))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-CHAD antibody (Catalog #: ARP51926_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CHAD (Chondroadherin (CHAD))
- Synonyms
- CHAD Peptide, zgc:63475 Peptide, SLRR4A Peptide, chondroadherin Peptide, CHAD Peptide, chad Peptide, Chad Peptide
- Background
-
Chondroadherin is a cartilage matrix protein thought to mediate adhesion of isolated chondrocytes. CHAD contains 11 leucine-rich repeats flanked by cysteine-rich regions. The chondroadherin messenger RNA is present in chondrocytes at all ages.Chondroadherin is a cartilage matrix protein thought to mediate adhesion of isolated chondrocytes. The protein contains 11 leucine-rich repeats flanked by cysteine-rich regions. The chondroadherin messenger RNA is present in chondrocytes at all ages.
Alias Symbols: SLRR4A
Protein Interaction Partner: COL2A1
Protein Size: 359 - Molecular Weight
- 38 kDa
- Gene ID
- 1101
- NCBI Accession
- NM_001267, NP_001258
- UniProt
- O15335
-